Search Results - "Júlio Maria Fonseca Chebli"

Refine Results
  1. 1
  2. 2
  3. 3

    A Rare Presentation of a Solid Pseudopapillary Neoplasm of the Pancreas by Silva, Raphael José da, Oliveira, Isaac Nilton Fernandes, Ribeiro, Tarsila Campanha da Rocha, Chebli, Liliana Andrade, Pace, Fábio Heleno de Lima, Chebli, Julio Maria Fonseca

    Published in GE Portuguese journal of gastroenterology (01-03-2022)
    “…Abstract Solid pseudopapillary neoplasms (SPN) are rare and represent a minority of all pancreatic cystic tumors. Symptoms, if present, are generally…”
    Get full text
    Journal Article
  4. 4

    PREVALENCE AND FACTORS ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN PATIENTS WITH CROHN'S DISEASE: A RETROSPECTIVE STUDY AT A REFERRAL CENTER by Bertges, Erika Ruback, Chebli, Júlio Maria Fonseca

    Published in Arquivos de gastroenterologia (01-09-2020)
    “…Small intestinal bacterial overgrowth (SIBO) appears to be common in patients with Crohn's disease (CD). The rate of SIBO has been estimated at 25%-88% in this…”
    Get full text
    Journal Article
  5. 5

    HIGH PREVALENCE OF NON-ADHERENCE TO ULCERATIVE COLITIS THERAPY IN REMISSION: KNOWING THE PROBLEM TO PREVENT LOSS by Franco, Fernanda Cristina Zimmermann, Oliveira, Mirella Chrispim Cerqueira de, Gaburri, Pedro Duarte, Franco, Danielle Cristina Zimmermann, Chebli, Júlio Maria Fonseca

    Published in Arquivos de gastroenterologia (01-03-2022)
    “…Ulcerative colitis (UC) is a chronic inflammatory disease whose manifestations can drastically affect the individual's quality of life, and therefore adherence…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    A guide to preparation of patients with inflammatory bowel diseases for anti-TNF-α therapy by Chebli, Júlio Maria Fonseca, Gaburri, Pedro Duarte, Chebli, Liliana Andrade, da Rocha Ribeiro, Tarsila Campanha, Pinto, André Luiz Tavares, Ambrogini, Orlando, Damião, Adérson Omar Mourão Cintra

    Published in Medical science monitor (26-03-2014)
    “…Current therapy of moderate-to-severe inflammatory bowel disease (IBD) often involves the use of anti-tumor necrosis factor alpha (TNF-α) agents. Although very…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17

    Muscle function and quality of life in the Crohn’s disease by Cabalzar, Andrea Lemos, Oliveira, Diana Junqueira Fonseca, Reboredo, Maycon de Moura, Lucca, Fernando Azevedo, Chebli, Júlio Maria Fonseca, Malaguti, Carla

    Published in Fisioterapia em movimento (01-04-2017)
    “…Abstract Introduction: Crohn’s disease (CD) is an inflammatory bowel disease, marked by exacerbations and remissions periods. Peripheral manifestations in CD…”
    Get full text
    Journal Article
  18. 18

    Fecal calprotectin and endoscopic scores: The cornerstones in clinical practice for evaluating mucosal healing in inflammatory bowel disease by Costa, Marcia Henriques de Magalhães, Sassaki, Ligia Yukie, Chebli, Júlio Maria Fonseca

    Published in World journal of gastroenterology : WJG (28-06-2024)
    “…Managing inflammatory bowel disease (IBD) is becoming increasingly complex and personalized, considering the advent of new advanced therapies with distinct…”
    Get full text
    Journal Article
  19. 19

    Interaction between diet and genetics in patients with inflammatory bowel disease by Magro, Daniéla Oliveira, Sassaki, Ligia Yukie, Chebli, Júlio Maria Fonseca

    Published in World journal of gastroenterology : WJG (28-03-2024)
    “…In this editorial, we comment on the article by Marangoni , published in the recent issue of the 2023; 29: 5618-5629, about "Diet as an epigenetic factor in…”
    Get full text
    Journal Article
  20. 20